Total Payments
$645.70
2024 Payments
$148.98
Companies
9
Transactions
34
Medicare Patients
1,664
Medicare Billing
$119,739
Payment Breakdown by Category
Food & Beverage$534.00 (82.7%)
Education$111.70 (17.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $534.00 | 32 | 82.7% |
| Education | $111.70 | 2 | 17.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $242.83 | 16 | $0 (2024) |
| Novo Nordisk Inc | $102.02 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $99.99 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.87 | 5 | $0 (2024) |
| Lilly USA, LLC | $26.66 | 2 | $0 (2022) |
| Ultragenyx Pharmaceutical Inc. | $23.40 | 1 | $0 (2023) |
| Corcept Therapeutics | $19.42 | 1 | $0 (2024) |
| ABBVIE INC. | $18.52 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $13.99 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $148.98 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($47.05) |
| 2023 | $299.31 | 13 | Astellas Pharma US Inc ($99.99) |
| 2022 | $119.76 | 8 | AstraZeneca Pharmaceuticals LP ($93.10) |
| 2021 | $77.65 | 5 | AstraZeneca Pharmaceuticals LP ($58.85) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Obesity | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Respiratory | ||||||
| 05/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: DIABETES | ||||||
| 01/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.60 | General |
| 01/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardio-renal | ||||||
| 12/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Respiratory | ||||||
| 10/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 10/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Respiratory | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory | ||||||
| 08/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 07/21/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 07/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Diabetes | ||||||
| 07/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: DIABETES | ||||||
| 02/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 01/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Obesity | ||||||
| 01/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 11/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Respiratory | ||||||
| 08/08/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Neuroscience | ||||||
| 07/20/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 356 | 475 | $56,585 | $24,334 |
| 2022 | 8 | 396 | 540 | $67,270 | $30,327 |
| 2021 | 11 | 459 | 637 | $76,984 | $36,323 |
| 2020 | 9 | 453 | 630 | $70,903 | $28,754 |
Total Patients
1,664
Total Services
2,282
Medicare Billing
$119,739
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 135 | $26,260 | $9,570 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $14,703 | $8,882 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 78 | $10,761 | $3,651 | 33.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 82 | $1,230 | $688.80 | 56.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 21 | $945.00 | $548.69 | 58.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 18 | $1,080 | $391.77 | 36.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $722.00 | $294.88 | 40.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 14 | $493.92 | $217.98 | 44.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 26 | $390.00 | $88.66 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 154 | $27,186 | $11,212 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 97 | 97 | $17,393 | $10,787 | 62.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 102 | $12,476 | $4,433 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 31 | $7,157 | $2,961 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $585.00 | $330.33 | 56.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 67 | 103 | $1,545 | $305.01 | 19.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 17 | $583.38 | $220.18 | 37.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 23 | $345.00 | $79.02 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 172 | $28,334 | $11,901 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 98 | 98 | $17,572 | $11,124 | 63.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 57 | $12,684 | $6,561 | 51.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 103 | $11,514 | $4,963 | 43.1% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 19 | 21 | $1,260 | $416.63 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 21 | $945.00 | $307.77 | 32.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 60 | 95 | $1,425 | $285.00 | 20.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 15 | 15 | $1,875 | $270.75 | 14.4% |
About Heide Applegate, FNP
Heide Applegate, FNP is a Family healthcare provider based in Deer Lodge, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043337140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heide Applegate, FNP has received a total of $645.70 in payments from pharmaceutical and medical device companies, with $148.98 received in 2024. These payments were reported across 34 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($534.00).
As a Medicare-enrolled provider, Applegate has provided services to 1,664 Medicare beneficiaries, totaling 2,282 services with total Medicare billing of $119,739. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Deer Lodge, MT
- Active Since 03/23/2007
- Last Updated 03/12/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043337140
Products in Payments
- BREZTRI (Drug) $125.62
- FARXIGA (Drug) $101.47
- JARDIANCE (Drug) $98.87
- Rybelsus (Drug) $33.79
- Wegovy (Drug) $33.36
- Korlym (Drug) $19.42
- Ozempic (Drug) $19.27
- QULIPTA (Drug) $18.52
- AIRSUPRA (Drug) $15.74
- EMGALITY (Drug) $14.95
- Kerendia (Drug) $13.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.